Suppr超能文献

治疗性白细胞去除术和血小板去除术在医学急症中的应用。

Therapeutic leukapheresis and thrombapheresis in medical emergencies.

机构信息

40 rue de Charigney, 25 000, Besançon, France.

Department of Cellular and Tissue Engineering, Etablissement Français du sang Bourgogne, Franche Comté, Besançon, France.

出版信息

Transfus Apher Sci. 2020 Dec;59(6):102997. doi: 10.1016/j.transci.2020.102997. Epub 2020 Nov 2.

Abstract

The management of hyperleukocytosis or thrombocytosis by therapeutic cytapheresis in the early 21 st century is far from codified (universal). Therapeutic cytapheresis have been proposed to achieve more rapid cytoreduction in peripheral blood than old universal support in order to quickly prevent potential complications. But, there are no randomized studies demonstrating the superiority of cytapheresis over other treatments alone. In this short review, based on our own experience (since 1980), we will give the indications and the role of cytapheresis procedures and we will try to answer the questions: when is therapeutic cytapheresis appropriate and do they still have a place in 2020, especially as a medical emergency?

摘要

在 21 世纪早期,通过治疗性血细胞分离术来管理高白细胞血症或血小板增多症,远未规范化(通用)。治疗性血细胞分离术被提议在早期外周血中实现比传统的支持治疗更迅速的细胞减少,以快速预防潜在的并发症。但是,没有随机研究表明血细胞分离术优于其他单独的治疗方法。在这篇简短的综述中,根据我们自己的经验(自 1980 年以来),我们将给出血细胞分离术的适应证和作用,并尝试回答以下问题:何时适合进行治疗性血细胞分离术,以及它们在 2020 年是否仍然有一席之地,特别是作为一种医疗急救手段?

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验